- Home
- JCAP vs OMCL Comparison
JCAP vs OMCL Comparison
Compare JCAP & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCAP
- OMCL
- Stock Information
- Founded
- JCAP 2002
- OMCL 1992
- Country
- JCAP United States
- OMCL United States
- Employees
- JCAP N/A
- OMCL N/A
- Industry
- JCAP
- OMCL Computer Manufacturing
- Sector
- JCAP
- OMCL Technology
- Exchange
- JCAP NYSE
- OMCL Nasdaq
- Market Cap
- JCAP 1.2B
- OMCL 1.3B
- IPO Year
- JCAP 2025
- OMCL 2001
- Fundamental
- Price
- JCAP $16.65
- OMCL $28.69
- Analyst Decision
- JCAP
- OMCL Buy
- Analyst Count
- JCAP 0
- OMCL 6
- Target Price
- JCAP N/A
- OMCL $44.83
- AVG Volume (30 Days)
- JCAP 627.5K
- OMCL 415.8K
- Earning Date
- JCAP 01-01-0001
- OMCL 07-31-2025
- Dividend Yield
- JCAP N/A
- OMCL N/A
- EPS Growth
- JCAP N/A
- OMCL N/A
- EPS
- JCAP N/A
- OMCL 0.45
- Revenue
- JCAP $485,042,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- JCAP N/A
- OMCL $3.84
- Revenue Next Year
- JCAP N/A
- OMCL $3.98
- P/E Ratio
- JCAP $6.79
- OMCL $63.65
- Revenue Growth
- JCAP 29.09
- OMCL 3.00
- 52 Week Low
- JCAP $16.40
- OMCL $22.66
- 52 Week High
- JCAP $19.55
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- JCAP N/A
- OMCL 43.98
- Support Level
- JCAP N/A
- OMCL $28.81
- Resistance Level
- JCAP N/A
- OMCL $30.19
- Average True Range (ATR)
- JCAP 0.00
- OMCL 0.88
- MACD
- JCAP 0.00
- OMCL 0.02
- Stochastic Oscillator
- JCAP 0.00
- OMCL 34.49
About JCAP JEFFERSON CAPITAL INC
Jefferson Capital Inc is a analytically driven purchaser and manager of charged-off and insolvency consumer accounts with operations in the United States, Canada, the United Kingdom and Latin America. Its accounts purchase are the unpaid obligations of individuals owed to credit grantors, which include banks, non-bank consumer lenders, auto finance companies, utilities and telecom companies.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.